Global Parkinson's Disease Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028 - Market Study Report

Global Parkinson's Disease Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Format: PDF | Report ID: 4656031 | Published Date: August 06, 2022

Choose License
The Parkinson's Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Parkinson's Disease Therapeutics market size is estimated to be worth US$ 2405.4 million in 2021 and is forecast to a readjusted size of USD 3558 million by 2028 with a CAGR of 5.8% during review period. Hospitals accounting for  % of the Parkinson's Disease Therapeutics global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While Oral segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Parkinson's Disease Therapeutics include Abbvie, Biogen, Boehringer Ingelheim GmbH, F. Hoffman-La Roche, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Parkinson's Disease Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Oral
    Transdermal
    Subcutaneous
    Intestinal Infusion
Market segment by Application, can be divided into
    Hospitals
    Clinics
    Others
Market segment by players, this report covers
    Abbvie
    Biogen
    Boehringer Ingelheim GmbH
    F. Hoffman-La Roche
    GlaxoSmithKline
    H. Lundbeck A/S
    Impax Labs
    Newron Pharmaceuticals SpA
    Novartis AG
    Orion Corporation
    Teva Pharmaceutical Industries Ltd.
    UCB S.A.
    Livzon Pharmaceutical
    Haisco Pharmaceutical
    Jingxin Pharmaceutical
    Dongcheng Biochemicals
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Parkinson's Disease Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Parkinson's Disease Therapeutics, with revenue, gross margin and global market share of Parkinson's Disease Therapeutics from 2019 to 2022.
Chapter 3, the Parkinson's Disease Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Parkinson's Disease Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Parkinson's Disease Therapeutics research findings and conclusion, appendix and data source.
1 Market Overview
    1.1 Product Overview and Scope of Parkinson's Disease Therapeutics
    1.2 Classification of Parkinson's Disease Therapeutics by Type
        1.2.1 Overview: Global Parkinson's Disease Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Type in 2021
        1.2.3 Oral
        1.2.4 Transdermal
        1.2.5 Subcutaneous
        1.2.6 Intestinal Infusion
    1.3 Global Parkinson's Disease Therapeutics Market by Application
        1.3.1 Overview: Global Parkinson's Disease Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global Parkinson's Disease Therapeutics Market Size & Forecast
    1.5 Global Parkinson's Disease Therapeutics Market Size and Forecast by Region
        1.5.1 Global Parkinson's Disease Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Parkinson's Disease Therapeutics Market Size by Region, (2017-2022)
        1.5.3 North America Parkinson's Disease Therapeutics Market Size and Prospect (2017-2028)
        1.5.4 Europe Parkinson's Disease Therapeutics Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Parkinson's Disease Therapeutics Market Size and Prospect (2017-2028)
        1.5.6 South America Parkinson's Disease Therapeutics Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Parkinson's Disease Therapeutics Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Parkinson's Disease Therapeutics Market Drivers
        1.6.2 Parkinson's Disease Therapeutics Market Restraints
        1.6.3 Parkinson's Disease Therapeutics Trends Analysis
2 Company Profiles
    2.1 Abbvie
        2.1.1 Abbvie Details
        2.1.2 Abbvie Major Business
        2.1.3 Abbvie Parkinson's Disease Therapeutics Product and Solutions
        2.1.4 Abbvie Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Abbvie Recent Developments and Future Plans
    2.2 Biogen
        2.2.1 Biogen Details
        2.2.2 Biogen Major Business
        2.2.3 Biogen Parkinson's Disease Therapeutics Product and Solutions
        2.2.4 Biogen Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Biogen Recent Developments and Future Plans
    2.3 Boehringer Ingelheim GmbH
        2.3.1 Boehringer Ingelheim GmbH Details
        2.3.2 Boehringer Ingelheim GmbH Major Business
        2.3.3 Boehringer Ingelheim GmbH Parkinson's Disease Therapeutics Product and Solutions
        2.3.4 Boehringer Ingelheim GmbH Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
    2.4 F. Hoffman-La Roche
        2.4.1 F. Hoffman-La Roche Details
        2.4.2 F. Hoffman-La Roche Major Business
        2.4.3 F. Hoffman-La Roche Parkinson's Disease Therapeutics Product and Solutions
        2.4.4 F. Hoffman-La Roche Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 F. Hoffman-La Roche Recent Developments and Future Plans
    2.5 GlaxoSmithKline
        2.5.1 GlaxoSmithKline Details
        2.5.2 GlaxoSmithKline Major Business
        2.5.3 GlaxoSmithKline Parkinson's Disease Therapeutics Product and Solutions
        2.5.4 GlaxoSmithKline Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 GlaxoSmithKline Recent Developments and Future Plans
    2.6 H. Lundbeck A/S
        2.6.1 H. Lundbeck A/S Details
        2.6.2 H. Lundbeck A/S Major Business
        2.6.3 H. Lundbeck A/S Parkinson's Disease Therapeutics Product and Solutions
        2.6.4 H. Lundbeck A/S Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 H. Lundbeck A/S Recent Developments and Future Plans
    2.7 Impax Labs
        2.7.1 Impax Labs Details
        2.7.2 Impax Labs Major Business
        2.7.3 Impax Labs Parkinson's Disease Therapeutics Product and Solutions
        2.7.4 Impax Labs Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Impax Labs Recent Developments and Future Plans
    2.8 Newron Pharmaceuticals SpA
        2.8.1 Newron Pharmaceuticals SpA Details
        2.8.2 Newron Pharmaceuticals SpA Major Business
        2.8.3 Newron Pharmaceuticals SpA Parkinson's Disease Therapeutics Product and Solutions
        2.8.4 Newron Pharmaceuticals SpA Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Newron Pharmaceuticals SpA Recent Developments and Future Plans
    2.9 Novartis AG
        2.9.1 Novartis AG Details
        2.9.2 Novartis AG Major Business
        2.9.3 Novartis AG Parkinson's Disease Therapeutics Product and Solutions
        2.9.4 Novartis AG Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Novartis AG Recent Developments and Future Plans
    2.10 Orion Corporation 
        2.10.1 Orion Corporation Details
        2.10.2 Orion Corporation Major Business
        2.10.3 Orion Corporation Parkinson's Disease Therapeutics Product and Solutions
        2.10.4 Orion Corporation Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Orion Corporation Recent Developments and Future Plans
    2.11 Teva Pharmaceutical Industries Ltd.
        2.11.1 Teva Pharmaceutical Industries Ltd. Details
        2.11.2 Teva Pharmaceutical Industries Ltd. Major Business
        2.11.3 Teva Pharmaceutical Industries Ltd. Parkinson's Disease Therapeutics Product and Solutions
        2.11.4 Teva Pharmaceutical Industries Ltd. Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
    2.12 UCB S.A.
        2.12.1 UCB S.A. Details
        2.12.2 UCB S.A. Major Business
        2.12.3 UCB S.A. Parkinson's Disease Therapeutics Product and Solutions
        2.12.4 UCB S.A. Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 UCB S.A. Recent Developments and Future Plans
    2.13 Livzon Pharmaceutical
        2.13.1 Livzon Pharmaceutical Details
        2.13.2 Livzon Pharmaceutical Major Business
        2.13.3 Livzon Pharmaceutical Parkinson's Disease Therapeutics Product and Solutions
        2.13.4 Livzon Pharmaceutical Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Livzon Pharmaceutical Recent Developments and Future Plans
    2.14 Haisco Pharmaceutical
        2.14.1 Haisco Pharmaceutical Details
        2.14.2 Haisco Pharmaceutical Major Business
        2.14.3 Haisco Pharmaceutical Parkinson's Disease Therapeutics Product and Solutions
        2.14.4 Haisco Pharmaceutical Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Haisco Pharmaceutical Recent Developments and Future Plans
    2.15 Jingxin Pharmaceutical
        2.15.1 Jingxin Pharmaceutical Details
        2.15.2 Jingxin Pharmaceutical Major Business
        2.15.3 Jingxin Pharmaceutical Parkinson's Disease Therapeutics Product and Solutions
        2.15.4 Jingxin Pharmaceutical Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Jingxin Pharmaceutical Recent Developments and Future Plans
    2.16 Dongcheng Biochemicals
        2.16.1 Dongcheng Biochemicals Details
        2.16.2 Dongcheng Biochemicals Major Business
        2.16.3 Dongcheng Biochemicals Parkinson's Disease Therapeutics Product and Solutions
        2.16.4 Dongcheng Biochemicals Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Dongcheng Biochemicals Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Parkinson's Disease Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Parkinson's Disease Therapeutics Players Market Share in 2021
        3.2.2 Top 10 Parkinson's Disease Therapeutics Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Parkinson's Disease Therapeutics Players Head Office, Products and Services Provided
    3.4 Parkinson's Disease Therapeutics Mergers & Acquisitions
    3.5 Parkinson's Disease Therapeutics New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Parkinson's Disease Therapeutics Revenue and Market Share by Type (2017-2022)
    4.2 Global Parkinson's Disease Therapeutics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2017-2022)
    5.2 Global Parkinson's Disease Therapeutics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Parkinson's Disease Therapeutics Revenue by Type (2017-2028)
    6.2 North America Parkinson's Disease Therapeutics Revenue by Application (2017-2028)
    6.3 North America Parkinson's Disease Therapeutics Market Size by Country
        6.3.1 North America Parkinson's Disease Therapeutics Revenue by Country (2017-2028)
        6.3.2 United States Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        6.3.3 Canada Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        6.3.4 Mexico Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Parkinson's Disease Therapeutics Revenue by Type (2017-2028)
    7.2 Europe Parkinson's Disease Therapeutics Revenue by Application (2017-2028)
    7.3 Europe Parkinson's Disease Therapeutics Market Size by Country
        7.3.1 Europe Parkinson's Disease Therapeutics Revenue by Country (2017-2028)
        7.3.2 Germany Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        7.3.3 France Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        7.3.5 Russia Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        7.3.6 Italy Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Parkinson's Disease Therapeutics Revenue by Type (2017-2028)
    8.2 Asia-Pacific Parkinson's Disease Therapeutics Revenue by Application (2017-2028)
    8.3 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region
        8.3.1 Asia-Pacific Parkinson's Disease Therapeutics Revenue by Region (2017-2028)
        8.3.2 China Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        8.3.3 Japan Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        8.3.4 South Korea Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        8.3.5 India Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        8.3.7 Australia Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Parkinson's Disease Therapeutics Revenue by Type (2017-2028)
    9.2 South America Parkinson's Disease Therapeutics Revenue by Application (2017-2028)
    9.3 South America Parkinson's Disease Therapeutics Market Size by Country
        9.3.1 South America Parkinson's Disease Therapeutics Revenue by Country (2017-2028)
        9.3.2 Brazil Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        9.3.3 Argentina Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Parkinson's Disease Therapeutics Revenue by Type (2017-2028)
    10.2 Middle East & Africa Parkinson's Disease Therapeutics Revenue by Application (2017-2028)
    10.3 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country
        10.3.1 Middle East & Africa Parkinson's Disease Therapeutics Revenue by Country (2017-2028)
        10.3.2 Turkey Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
        10.3.4 UAE Parkinson's Disease Therapeutics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global Parkinson's Disease Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028 Table 2. Global Parkinson's Disease Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028 Table 3. Global Market Parkinson's Disease Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028) Table 4. Global Parkinson's Disease Therapeutics Revenue (USD Million) by Region (2017-2022) Table 5. Global Parkinson's Disease Therapeutics Revenue Market Share by Region (2023-2028) Table 6. Abbvie Corporate Information, Head Office, and Major Competitors Table 7. Abbvie Major Business Table 8. Abbvie Parkinson's Disease Therapeutics Product and Solutions Table 9. Abbvie Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 10. Biogen Corporate Information, Head Office, and Major Competitors Table 11. Biogen Major Business Table 12. Biogen Parkinson's Disease Therapeutics Product and Solutions Table 13. Biogen Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 14. Boehringer Ingelheim GmbH Corporate Information, Head Office, and Major Competitors Table 15. Boehringer Ingelheim GmbH Major Business Table 16. Boehringer Ingelheim GmbH Parkinson's Disease Therapeutics Product and Solutions Table 17. Boehringer Ingelheim GmbH Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 18. F. Hoffman-La Roche Corporate Information, Head Office, and Major Competitors Table 19. F. Hoffman-La Roche Major Business Table 20. F. Hoffman-La Roche Parkinson's Disease Therapeutics Product and Solutions Table 21. F. Hoffman-La Roche Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 22. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors Table 23. GlaxoSmithKline Major Business Table 24. GlaxoSmithKline Parkinson's Disease Therapeutics Product and Solutions Table 25. GlaxoSmithKline Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 26. H. Lundbeck A/S Corporate Information, Head Office, and Major Competitors Table 27. H. Lundbeck A/S Major Business Table 28. H. Lundbeck A/S Parkinson's Disease Therapeutics Product and Solutions Table 29. H. Lundbeck A/S Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 30. Impax Labs Corporate Information, Head Office, and Major Competitors Table 31. Impax Labs Major Business Table 32. Impax Labs Parkinson's Disease Therapeutics Product and Solutions Table 33. Impax Labs Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 34. Newron Pharmaceuticals SpA Corporate Information, Head Office, and Major Competitors Table 35. Newron Pharmaceuticals SpA Major Business Table 36. Newron Pharmaceuticals SpA Parkinson's Disease Therapeutics Product and Solutions Table 37. Newron Pharmaceuticals SpA Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 38. Novartis AG Corporate Information, Head Office, and Major Competitors Table 39. Novartis AG Major Business Table 40. Novartis AG Parkinson's Disease Therapeutics Product and Solutions Table 41. Novartis AG Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 42. Orion Corporation Corporate Information, Head Office, and Major Competitors Table 43. Orion Corporation Major Business Table 44. Orion Corporation Parkinson's Disease Therapeutics Product and Solutions Table 45. Orion Corporation Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 46. Teva Pharmaceutical Industries Ltd. Corporate Information, Head Office, and Major Competitors Table 47. Teva Pharmaceutical Industries Ltd. Major Business Table 48. Teva Pharmaceutical Industries Ltd. Parkinson's Disease Therapeutics Product and Solutions Table 49. Teva Pharmaceutical Industries Ltd. Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 50. UCB S.A. Corporate Information, Head Office, and Major Competitors Table 51. UCB S.A. Major Business Table 52. UCB S.A. Parkinson's Disease Therapeutics Product and Solutions Table 53. UCB S.A. Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 54. Livzon Pharmaceutical Corporate Information, Head Office, and Major Competitors Table 55. Livzon Pharmaceutical Major Business Table 56. Livzon Pharmaceutical Parkinson's Disease Therapeutics Product and Solutions Table 57. Livzon Pharmaceutical Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 58. Haisco Pharmaceutical Corporate Information, Head Office, and Major Competitors Table 59. Haisco Pharmaceutical Major Business Table 60. Haisco Pharmaceutical Parkinson's Disease Therapeutics Product and Solutions Table 61. Haisco Pharmaceutical Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 62. Jingxin Pharmaceutical Corporate Information, Head Office, and Major Competitors Table 63. Jingxin Pharmaceutical Major Business Table 64. Jingxin Pharmaceutical Parkinson's Disease Therapeutics Product and Solutions Table 65. Jingxin Pharmaceutical Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 66. Dongcheng Biochemicals Corporate Information, Head Office, and Major Competitors Table 67. Dongcheng Biochemicals Major Business Table 68. Dongcheng Biochemicals Parkinson's Disease Therapeutics Product and Solutions Table 69. Dongcheng Biochemicals Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 70. Global Parkinson's Disease Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022) Table 71. Global Parkinson's Disease Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022) Table 72. Breakdown of Parkinson's Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) Table 73. Parkinson's Disease Therapeutics Players Head Office, Products and Services Provided Table 74. Parkinson's Disease Therapeutics Mergers & Acquisitions in the Past Five Years Table 75. Parkinson's Disease Therapeutics New Entrants and Expansion Plans Table 76. Global Parkinson's Disease Therapeutics Revenue (USD Million) by Type (2017-2022) Table 77. Global Parkinson's Disease Therapeutics Revenue Share by Type (2017-2022) Table 78. Global Parkinson's Disease Therapeutics Revenue Forecast by Type (2023-2028) Table 79. Global Parkinson's Disease Therapeutics Revenue by Application (2017-2022) Table 80. Global Parkinson's Disease Therapeutics Revenue Forecast by Application (2023-2028) Table 81. North America Parkinson's Disease Therapeutics Revenue by Type (2017-2022) & (USD Million) Table 82. North America Parkinson's Disease Therapeutics Revenue by Type (2023-2028) & (USD Million) Table 83. North America Parkinson's Disease Therapeutics Revenue by Application (2017-2022) & (USD Million) Table 84. North America Parkinson's Disease Therapeutics Revenue by Application (2023-2028) & (USD Million) Table 85. North America Parkinson's Disease Therapeutics Revenue by Country (2017-2022) & (USD Million) Table 86. North America Parkinson's Disease Therapeutics Revenue by Country (2023-2028) & (USD Million) Table 87. Europe Parkinson's Disease Therapeutics Revenue by Type (2017-2022) & (USD Million) Table 88. Europe Parkinson's Disease Therapeutics Revenue by Type (2023-2028) & (USD Million) Table 89. Europe Parkinson's Disease Therapeutics Revenue by Application (2017-2022) & (USD Million) Table 90. Europe Parkinson's Disease Therapeutics Revenue by Application (2023-2028) & (USD Million) Table 91. Europe Parkinson's Disease Therapeutics Revenue by Country (2017-2022) & (USD Million) Table 92. Europe Parkinson's Disease Therapeutics Revenue by Country (2023-2028) & (USD Million) Table 93. Asia-Pacific Parkinson's Disease Therapeutics Revenue by Type (2017-2022) & (USD Million) Table 94. Asia-Pacific Parkinson's Disease Therapeutics Revenue by Type (2023-2028) & (USD Million) Table 95. Asia-Pacific Parkinson's Disease Therapeutics Revenue by Application (2017-2022) & (USD Million) Table 96. Asia-Pacific Parkinson's Disease Therapeutics Revenue by Application (2023-2028) & (USD Million) Table 97. Asia-Pacific Parkinson's Disease Therapeutics Revenue by Region (2017-2022) & (USD Million) Table 98. Asia-Pacific Parkinson's Disease Therapeutics Revenue by Region (2023-2028) & (USD Million) Table 99. South America Parkinson's Disease Therapeutics Revenue by Type (2017-2022) & (USD Million) Table 100. South America Parkinson's Disease Therapeutics Revenue by Type (2023-2028) & (USD Million) Table 101. South America Parkinson's Disease Therapeutics Revenue by Application (2017-2022) & (USD Million) Table 102. South America Parkinson's Disease Therapeutics Revenue by Application (2023-2028) & (USD Million) Table 103. South America Parkinson's Disease Therapeutics Revenue by Country (2017-2022) & (USD Million) Table 104. South America Parkinson's Disease Therapeutics Revenue by Country (2023-2028) & (USD Million) Table 105. Middle East & Africa Parkinson's Disease Therapeutics Revenue by Type (2017-2022) & (USD Million) Table 106. Middle East & Africa Parkinson's Disease Therapeutics Revenue by Type (2023-2028) & (USD Million) Table 107. Middle East & Africa Parkinson's Disease Therapeutics Revenue by Application (2017-2022) & (USD Million) Table 108. Middle East & Africa Parkinson's Disease Therapeutics Revenue by Application (2023-2028) & (USD Million) Table 109. Middle East & Africa Parkinson's Disease Therapeutics Revenue by Country (2017-2022) & (USD Million) Table 110. Middle East & Africa Parkinson's Disease Therapeutics Revenue by Country (2023-2028) & (USD Million) List of Figures Figure 1. Parkinson's Disease Therapeutics Picture Figure 2. Global Parkinson's Disease Therapeutics Revenue Market Share by Type in 2021 Figure 3. Oral Figure 4. Transdermal Figure 5. Subcutaneous Figure 6. Intestinal Infusion Figure 7. Parkinson's Disease Therapeutics Revenue Market Share by Application in 2021 Figure 8. Hospitals Picture Figure 9. Clinics Picture Figure 10. Others Picture Figure 11. Global Parkinson's Disease Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028 Figure 12. Global Parkinson's Disease Therapeutics Revenue and Forecast (2017-2028) & (USD Million) Figure 13. Global Parkinson's Disease Therapeutics Revenue Market Share by Region (2017-2028) Figure 14. Global Parkinson's Disease Therapeutics Revenue Market Share by Region in 2021 Figure 15. North America Parkinson's Disease Therapeutics Revenue (USD Million) and Growth Rate (2017-2028) Figure 16. Europe Parkinson's Disease Therapeutics Revenue (USD Million) and Growth Rate (2017-2028) Figure 17. Asia-Pacific Parkinson's Disease Therapeutics Revenue (USD Million) and Growth Rate (2017-2028) Figure 18. South America Parkinson's Disease Therapeutics Revenue (USD Million) and Growth Rate (2017-2028) Figure 19. Middle East and Africa Parkinson's Disease Therapeutics Revenue (USD Million) and Growth Rate (2017-2028) Figure 20. Parkinson's Disease Therapeutics Market Drivers Figure 21. Parkinson's Disease Therapeutics Market Restraints Figure 22. Parkinson's Disease Therapeutics Market Trends Figure 23. Abbvie Recent Developments and Future Plans Figure 24. Biogen Recent Developments and Future Plans Figure 25. Boehringer Ingelheim GmbH Recent Developments and Future Plans Figure 26. F. Hoffman-La Roche Recent Developments and Future Plans Figure 27. GlaxoSmithKline Recent Developments and Future Plans Figure 28. H. Lundbeck A/S Recent Developments and Future Plans Figure 29. Impax Labs Recent Developments and Future Plans Figure 30. Newron Pharmaceuticals SpA Recent Developments and Future Plans Figure 31. Novartis AG Recent Developments and Future Plans Figure 32. Orion Corporation Recent Developments and Future Plans Figure 33. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans Figure 34. UCB S.A. Recent Developments and Future Plans Figure 35. Livzon Pharmaceutical Recent Developments and Future Plans Figure 36. Haisco Pharmaceutical Recent Developments and Future Plans Figure 37. Jingxin Pharmaceutical Recent Developments and Future Plans Figure 38. Dongcheng Biochemicals Recent Developments and Future Plans Figure 39. Global Parkinson's Disease Therapeutics Revenue Share by Players in 2021 Figure 40. Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021 Figure 41. Global Top 3 Players Parkinson's Disease Therapeutics Revenue Market Share in 2021 Figure 42. Global Top 10 Players Parkinson's Disease Therapeutics Revenue Market Share in 2021 Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022) Figure 44. Global Parkinson's Disease Therapeutics Revenue Share by Type in 2021 Figure 45. Global Parkinson's Disease Therapeutics Market Share Forecast by Type (2023-2028) Figure 46. Global Parkinson's Disease Therapeutics Revenue Share by Application in 2021 Figure 47. Global Parkinson's Disease Therapeutics Market Share Forecast by Application (2023-2028) Figure 48. North America Parkinson's Disease Therapeutics Sales Market Share by Type (2017-2028) Figure 49. North America Parkinson's Disease Therapeutics Sales Market Share by Application (2017-2028) Figure 50. North America Parkinson's Disease Therapeutics Revenue Market Share by Country (2017-2028) Figure 51. United States Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 52. Canada Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 53. Mexico Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 54. Europe Parkinson's Disease Therapeutics Sales Market Share by Type (2017-2028) Figure 55. Europe Parkinson's Disease Therapeutics Sales Market Share by Application (2017-2028) Figure 56. Europe Parkinson's Disease Therapeutics Revenue Market Share by Country (2017-2028) Figure 57. Germany Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 58. France Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 59. United Kingdom Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 60. Russia Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 61. Italy Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 62. Asia-Pacific Parkinson's Disease Therapeutics Sales Market Share by Type (2017-2028) Figure 63. Asia-Pacific Parkinson's Disease Therapeutics Sales Market Share by Application (2017-2028) Figure 64. Asia-Pacific Parkinson's Disease Therapeutics Revenue Market Share by Region (2017-2028) Figure 65. China Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 66. Japan Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 67. South Korea Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 68. India Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 69. Southeast Asia Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 70. Australia Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 71. South America Parkinson's Disease Therapeutics Sales Market Share by Type (2017-2028) Figure 72. South America Parkinson's Disease Therapeutics Sales Market Share by Application (2017-2028) Figure 73. South America Parkinson's Disease Therapeutics Revenue Market Share by Country (2017-2028) Figure 74. Brazil Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 75. Argentina Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 76. Middle East and Africa Parkinson's Disease Therapeutics Sales Market Share by Type (2017-2028) Figure 77. Middle East and Africa Parkinson's Disease Therapeutics Sales Market Share by Application (2017-2028) Figure 78. Middle East and Africa Parkinson's Disease Therapeutics Revenue Market Share by Country (2017-2028) Figure 79. Turkey Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 80. Saudi Arabia Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 81. UAE Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million) Figure 82. Methodology Figure 83. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch

Budget constraint? Get in touch to get special pricing offers


Request For Discount

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us